Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 29% ± 16% | |
adipocyte | 9 studies | 36% ± 14% | |
astrocyte | 8 studies | 29% ± 12% | |
retinal ganglion cell | 6 studies | 43% ± 20% | |
epithelial cell | 6 studies | 36% ± 21% | |
fibroblast | 6 studies | 22% ± 10% | |
oligodendrocyte | 6 studies | 26% ± 7% | |
glutamatergic neuron | 5 studies | 45% ± 23% | |
microglial cell | 5 studies | 20% ± 4% | |
OFF-bipolar cell | 5 studies | 35% ± 14% | |
retina horizontal cell | 5 studies | 23% ± 3% | |
retinal rod cell | 5 studies | 22% ± 4% | |
cardiac muscle cell | 5 studies | 32% ± 9% | |
ciliated cell | 5 studies | 20% ± 2% | |
classical monocyte | 4 studies | 21% ± 4% | |
retinal bipolar neuron | 4 studies | 51% ± 11% | |
ON-bipolar cell | 4 studies | 34% ± 11% | |
myeloid cell | 4 studies | 17% ± 1% | |
amacrine cell | 4 studies | 21% ± 3% | |
Mueller cell | 4 studies | 22% ± 4% | |
GABAergic neuron | 4 studies | 43% ± 18% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 7% | |
monocyte | 4 studies | 18% ± 3% | |
type I pneumocyte | 4 studies | 19% ± 3% | |
interneuron | 4 studies | 33% ± 19% | |
pancreatic A cell | 3 studies | 28% ± 8% | |
hematopoietic precursor cell | 3 studies | 21% ± 4% | |
non-classical monocyte | 3 studies | 22% ± 7% | |
rod bipolar cell | 3 studies | 60% ± 5% | |
abnormal cell | 3 studies | 22% ± 8% | |
hepatocyte | 3 studies | 35% ± 17% | |
basal cell | 3 studies | 46% ± 29% | |
goblet cell | 3 studies | 29% ± 13% | |
transit amplifying cell | 3 studies | 43% ± 38% | |
neuron | 3 studies | 27% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3775.54 | 1445 / 1445 | 100% | 29.75 | 183 / 183 |
prostate | 100% | 2597.73 | 245 / 245 | 100% | 32.84 | 502 / 502 |
skin | 100% | 3822.63 | 1809 / 1809 | 100% | 49.97 | 472 / 472 |
breast | 100% | 3670.16 | 459 / 459 | 100% | 32.65 | 1117 / 1118 |
kidney | 100% | 3649.02 | 89 / 89 | 100% | 34.59 | 899 / 901 |
brain | 100% | 2559.13 | 2636 / 2642 | 100% | 35.16 | 705 / 705 |
stomach | 100% | 2242.86 | 359 / 359 | 100% | 21.16 | 285 / 286 |
intestine | 100% | 3210.59 | 966 / 966 | 100% | 22.08 | 525 / 527 |
bladder | 100% | 3304.19 | 21 / 21 | 100% | 23.66 | 502 / 504 |
lung | 100% | 2563.52 | 576 / 578 | 100% | 30.62 | 1154 / 1155 |
ovary | 100% | 2094.29 | 180 / 180 | 100% | 16.88 | 428 / 430 |
thymus | 100% | 2401.79 | 652 / 653 | 100% | 27.92 | 603 / 605 |
uterus | 100% | 2139.47 | 170 / 170 | 99% | 23.05 | 456 / 459 |
liver | 100% | 2088.18 | 225 / 226 | 100% | 19.93 | 405 / 406 |
adrenal gland | 100% | 5468.71 | 258 / 258 | 99% | 32.75 | 228 / 230 |
pancreas | 99% | 1897.84 | 325 / 328 | 99% | 21.80 | 177 / 178 |
adipose | 100% | 4139.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2472.07 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 60.70 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.10 | 29 / 29 |
muscle | 100% | 10173.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2031.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.57 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.35 | 1 / 1 |
heart | 97% | 3507.95 | 831 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 1799.01 | 892 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_0005515 | Molecular function | protein binding |
Gene name | BCL2L13 |
Protein name | BCL2-like 13 (Apoptosis facilitator), isoform CRA_c (cDNA, FLJ95299, highly similar to Homo sapiens BCL2-like 13 (apoptosis facilitator) (BCL2L13),nuclear gene encoding mitochondrial protein, mRNA) Bcl-2-like protein 13 (Bcl2-L-13) (Bcl-rambo) (Protein Mil1) BCL2 like 13 |
Synonyms | MIL1 hCG_19914 CD003 |
Description | FUNCTION: May promote the activation of caspase-3 and apoptosis. |
Accessions | ENST00000543133.5 [Q9BXK5-4] ENST00000498133.5 A0A087WX97 F6VJB4 ENST00000317582.10 [Q9BXK5-1] ENST00000418951.6 [Q9BXK5-4] ENST00000399777.1 ENST00000616863.4 ENST00000337612.9 E9PDD6 ENST00000399782.5 [Q9BXK5-2] F2Z2C3 ENST00000355028.4 ENST00000538149.5 ENST00000611738.4 B2RB43 ENST00000618481.4 ENST00000493680.5 [Q9BXK5-2] H0Y3R5 A0A0A0MR90 A0A087WW80 Q9BXK5 A0A087WTL4 |